Professur für Translationale Frauenheilkunde und Geburtshilfe

Galactography with Tomosynthesis Technique (Galactomosynthesis) - Renaissance of a Method? (2018) Schulz-Wendtland R, Preuss C, Fasching P, Löhberg C, Lux MP, Emons J, Beckmann M, et al. Journal article Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer (2018) Woeckel A, Festl J, Stueber T, Brust K, Krockenberger M, Heuschmann PU, Jiru-Hillmann S, et al. Journal article Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer (2018) Woeckel A, Festl J, Stueber T, Brust K, Stangl S, Heuschmann PU, Albert US, et al. Journal article rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology (2018) Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching P, Beckmann M, Ekici AB, et al. Journal article ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro (2018) Schmid R, Wolf K, Robering JW, Strauss S, Strissel P, Strick R, Rübner M, et al. Journal article TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes (2018) Erber R, Hartmann A, Beckmann M, Mackensen A, Kremer A, Reimann H, Hübner H, et al. Journal article Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer (2018) Gaß P, Lux MP, Rauh C, Hein A, Bani M, Fießler C, Hartmann A, et al. Journal article Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS) (2018) Gebrekidan M, Erber R, Hartmann A, Fasching P, Emons J, Beckmann M, Bräuer A Journal article The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer (2018) Brennan M, Gaß P, Häberle L, Wang D, Hartmann A, Lux MP, Beckmann M, et al. Journal article Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians (2018) Gaß P, Untch M, Mueller V, Moebus V, Thomssen C, Häberle L, Erber R, et al. Journal article